成都轻度脉管炎如何治疗(成都腿部血管炎医院) (今日更新中)

WASHINGTON, Nov. 14 (Xinhua) -- Nearly a fifth of all Americans 12 years or older have hearing loss so severe that it may make communication difficult, according to a new study led by Johns Hopkins University researchers and published Monday in the Archives of Internal Medicine.The findings, thought to be the first nationally representative estimate of hearing loss, suggest that many more people than previously thought are affected by this condition.Study leader Frank Lin, an assistant professor, and his colleagues used data from the National Health and Nutritional Examination Surveys (NHANES), a research program that has periodically gathered health data from thousands of Americans since 1971. The researchers analyzed data from all participants age 12 and over whose hearing was tested during NHANES examinations from 2001 to 2008. Unlike previous estimates, NHANES includes men and women of all races and ages, from cities scattered across the country, so it's thought to statistically mimic the population of the Untied States.Using the World Health Organization's definition for hearing loss (not being able to hear sounds of 25 decibels or less in the speech frequencies), the researchers found that overall, about 30 million Americans, or 12.7 percent of the population, had hearing loss in both ears. That number jumps to about 48 million, or 20.3 percent, for people who have hearing loss in at least one ear. These numbers far surpass previous estimates of 21 to 29 million.Hearing loss prevalence nearly doubled with every age decade, with women and blacks being significantly less likely to have hearing loss at any age. Lin and his colleagues aren't sure why these groups appear to be protected. However, he notes that the female hormone estrogen, as well as the melanin pigment in darker skin, could have a protective effect on the inner ear.

BEIJING, Nov. 25 (Xinhua) -- The Ministry of Commerce (MOC) said Friday that it will start an investigation into the U.S. government's policy support and subsidies for its renewable energy sector over trade barrier concerns.The MOC will look into six renewable energy programs concerning wind, solar and hydroelectric energy in the states of Washington, Massachusetts, Ohio, New Jersey and California, the MOC said in a statement posted on its website.The investigation was applied for by the China Chamber of Commerce for Imports and Exports of Machinery and Electronic Products, as well as the new energy chamber of the All-China Federation of Industry and Commerce."The applicants argued that the U.S. government's policy support and subsidies for its renewable energy industry constitute a trade barrier, as they violate the rules of the World Trade Organization and have hindered and restricted the development of China's renewable energy sector," the statement said.The applicants requested the elimination of any negative influence from the U.S. government's policy support and subsidies in order to maintain a fair trade environment, according to the statement.The investigation will end before May 25, 2012, although it may be extended to August 25, 2012 under special circumstances, according to the statement.

BEIJING, Oct. 13 (Xinhuanet) -- Scientists have decoded the genome of Black Death which caused one of the worst plagues in human history.The finding was published Wednesday in the scientific journal Nature.A team of German, Canadian and American scientists collected the bacteria's DNA from ancient plague victims' teeth and bones, which were excavated from the burial ground in London.With a careful NDA comparison between the ancient bacteria and the modern strains, scientists found the direct variant of the medieval bacteria still exist today.Black Death's descendants kill around 2,000 people a year, mostly in the developing world, the scientist said."This will provide us with direct insights into the evolution of human pathogens and historical pandemics," said Johannes Krause Of Germany's University of Tubingen, who worked on the study.Black Death, the fatal plague of medieval Europe, wiped out some 30 million people -- about 50 percent of the population on the continent, within just five years, between 1347 and 1351.

BEIJING, Oct. 28 (Xinhuanet) -- Taking aspirin everyday may lower the risk of developing colon cancer for people with the cancer-causing genes, researchers found.The finding was published on Friday in the British medical journal "Lancet".The researchers followed 508 patients with Lynch syndrome, an inherited disorder which increases the risk of developing colon and other cancers.These patients were divided into two groups: members in one group took 600 mg aspirins everyday; another group took only the dummy pills.After 4 years, 10 colon cancer cases were reported among 258 patients who took daily aspirins for at least two years, comparing with 23 cases among 250 patients on dummy pills."This is good news for a very specific population," said Asad Umar, a cancer prevention expert at the U.S. National Cancer Institute.However, the finding doesn't apply to the general public, suggested the lead author of the study John Burn, a geneticist at Newcastle University in England.Only those who are at risk of such diseases should consider taking aspirin regularly, such as people having a family history of colon cancer, he added.

JERUSALEM, Jan. 12 (Xinhua) -- An Israeli company has developed a system that scans the brain and provides a three dimensional image of the nerve cell connectivity to treat brain diseases like Alzheimer's or HDHD.The firm ElMindA trademarked a non-invasive system, the BNA ( Brain Network Activation), that helps doctors visualize the connectivity between nerve cells and synchronization that can even measure the severity of the patients condition from one day to another, the Israel21c news site reported on ThursdayBy creating a three-dimensional image of the brain while asking the patients to repeat an activity several times, BNA developers hope this system will become a regular way of diagnosing brain illnesses."Our vision is that every psychiatrist and neurologist in the world will routinely send every patient for BNA tests," said Dr. Eli Zangvil, ElMindA's strategic advisor for business development. "Our test would add information and aid in diagnostics in a way no other existing technology can do," he added.BNA could help doctors find out exactly at what stage of the disease patients and prescribe the exact medication for them."To do that, we must collect a lot of data," Zangvil said. "To say this person has a certain disease or condition, I have to be able to compare their pattern to a normal brain pattern of a person of the same age and gender." he said.Researchers hope to gather the amount of data they need to obtain FDA approval in the U.S. by the end of 2012, and start marketing it to hospitals by 2013.

来源：资阳报